NCT01154777

Brief Summary

Neurofeedback, a neuro-cognitive training method based on operant conditioning, will be employed with 90 children with the Autistic Spectrum Disorders (ASD) over a 60 session training period to improve the limiting behavioral and sensory symptoms Autism presents (with each collaborative site working with 45 of the 90 participants). This study seeks to demonstrate that Neurofeedback training, a non-invasive approach based on Learning Theory, will mitigate presenting symptoms of Autism, and ultimately render the person with Autism significantly more able to interact with his/her environment successfully, independently function on a day-to-day basis, and improve overall mental health.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Jul 2011

Longer than P75 for phase_1

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 1, 2010

Completed
1 year until next milestone

Study Start

First participant enrolled

July 1, 2011

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

October 5, 2010

Status Verified

October 1, 2010

Enrollment Period

4.9 years

First QC Date

June 29, 2010

Last Update Submit

October 3, 2010

Conditions

Keywords

NeurofeedbackBraintrainingAutismMildModerateMild to Moderate Autism

Outcome Measures

Primary Outcomes (1)

  • Level of normalization of brainwaves based upon QEEG

    After completion of all neurofeedback sessions, post-training evaluation will include cognitive testing, completion of ASRS and ATEC forms and a post-QEEG. Interviews with parents will also be conducted to identify progress and changes in symptom presentation.

    Pre - training, 20 and 40 Session Interims, and post-training

Interventions

60 sessions of Neurofeedback on 6-18 year olds with Autism

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • to 18 year olds who have been diagnosed by their physician with mild to moderate autism, in accordance with DSM-IV diagnostic criteria

You may not qualify if:

  • Any child with a diagnosis of Bipolar Disorder, Tourette's Syndrome, an uncontrolled seizure disorder, or a history of any major psychiatric disorder will be excluded from eligibility for the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Institute for Personal Excellence, P.A.

Raleigh, North Carolina, 27607, United States

Location

Life Quality Resources

Raleigh, North Carolina, 27612, United States

Location

Related Links

MeSH Terms

Conditions

Autistic DisorderLymphoma, Follicular

Condition Hierarchy (Ancestors)

Autism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersLymphoma, Non-HodgkinLymphomaNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Officials

  • Magdalena M Gebska-Wojdynska, M.D.

    Institute for Personal Excellence, P.A.

    PRINCIPAL INVESTIGATOR
  • Lucy Chartier, Ph.D., NP

    Life Quality Resources

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 1
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 29, 2010

First Posted

July 1, 2010

Study Start

July 1, 2011

Primary Completion

June 1, 2016

Study Completion

December 1, 2016

Last Updated

October 5, 2010

Record last verified: 2010-10

Locations